614 Elective Bariatric and Metabolic Surgery in United Kingdom During the Coronavirus Pandemic

Abstract Aim Elective Bariatric and Metabolic Surgery (BMS) was halted in the UK during first wave of Coronavirus (COVID-19) pandemic. Obesity is a predictor poor outcome those infected with this virus. This study reports our experience resuming elective weight loss surgery safely amidst Method Guidance from national bodies (BOMSS/NICE) were reviewed Standard Operating Procedure (SOP) drafted to accommodate local considerations. Data prospectively collected on patients undergoing BMS following commencement after lockdown. Results A total 50 underwent at institution within six weeks services. The median age 41 years old BMI 43.8(IQR 40.0-48.8 kg/m2). Equal number laparoscopic Sleeve Gastrectomy (SG) Roux en-Y Gastric Bypass (RYGB). Of these, 9 (18%) had revisional 48 (96%) discharged 24 hours their surgery. rate readmission thirty days 6% (n = 3) 1 patient returned theatre an obstruction proximal jejuno-jenunal anastomosis. None exhibited symptoms or tested positive for COVID-19 Conclusions With appropriate precautions protocols, it feasible safe resume BMS, no increased risk bariatric particularly encouraging other units offer current